Cubist Systematic Strategies’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Cubist Systematic Strategies’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,000	Closed	-$225K	–	4725
2022 Q3	$225K	Buy	+1,000	New	+$202K	﹤0.01%	3690

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Cubist Systematic Strategies's KRTX Position: Q1 2024 in Review

Cubist Systematic Strategies sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 14,560 shares — an estimated $4.61M sold.

Cubist Systematic Strategies first reported a position in KRTX in Q3 2019 and held it in 14 quarters. The position peaked at $6.78M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Cubist Systematic Strategies reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Cubist Systematic Strategies sold 14,560 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $4.61M.
Cubist Systematic Strategies first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2019 and held it in 14 quarters.
Cubist Systematic Strategies's Karuna Therapeutics, Inc. Common Stock position peaked at $6.78M in Q3 2022.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.